Narayana Hrudayalaya Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Narayana Hrudayalaya Ltd is ₹ 1647 as of 23 Oct 15:30 . The P/E Ratio of Narayana Hrudayalaya Ltd changed from 44.6 on March 2022 to 40.7 on March 2026 . This represents a CAGR of -1.81% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Narayana Hrudayalaya Ltd changed from ₹ 8299 crore on March 2021 to ₹ 32813 crore on March 2026 . This represents a CAGR of 25.75% over 6 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Narayana Hrudayalaya Ltd for the Jun '26 is ₹ 2719 crore as compare to the Mar '26 revenue of ₹ 2623 crore. This represent the growth of 3.66% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Narayana Hrudayalaya Ltd for the Jun '26 is ₹ 503.27 crore as compare to the Mar '26 ebitda of ₹ 533.16 crore. This represent the decline of -5.61% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Narayana Hrudayalaya Ltd changed from ₹ 201.49 crore to ₹ 207.27 crore over 9 quarters. This represents a CAGR of 1.26% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Narayana Hrudayalaya Ltd changed from 15.3 % on March 2022 to 18.28 % on March 2026 . This represents a CAGR of 3.62% over 5 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Limited was incorporated on 19 July 2000 by Dr. Devi Prasad Shetty as its Founder.
The Company is primarily engaged in the business of rendering medical and healthcare services.
It has a network of multispeciality, and super speciality hospitals spread across multiple locations.
The Company owns and operates certain hospitals and also enters into management agreements with hospitals under which the Company acquires the operating control of the hospitals. During the financial year ended 31 March 2016, Company acquired the entire remaining 26% in Narayana Hrudayalaya Surgical Hospital Private Limited (NHSHPL) from Infrastructure Development Corporation (Karnataka) Limited (IDECK) by paying Rs 3,025.60 Lacs as total purchase consideration to make NHSHPL as its wholly owned subsidiary.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Narayana Hrudayalaya Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Narayana Hrudayalaya Ltd or Transgene Biotek Ltd?

Market cap of Narayana Hrudayalaya Ltd is 33,658 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of Narayana Hrudayalaya Ltd and Transgene Biotek Ltd?

The stock performance of Narayana Hrudayalaya Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Narayana Hrudayalaya Ltd and Transgene Biotek Ltd?

As of October 25, 2026, the Narayana Hrudayalaya Ltd stock price is INR ₹1647.0. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of Narayana Hrudayalaya Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Narayana Hrudayalaya Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.